Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Long-term efficacy of Gilenya® reinforced by new 'no evidence of disease activity' (NEDA-4) analysis in MS patients over seven years
[Consensus document on spasticity in patients with multiple sclerosis.]
Optic nerve head component analysis enters the clinic: Will multifocal ERG be the next OCT?
MRI of the cervical nerve roots in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy: a single-institution, retrospective case-control study.
Microtubule-stabilizing agents delay the onset of EAE through inhibition of migration.
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK.
Disease-modifying therapies and infectious risks in multiple sclerosis.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Yes.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis.
Place of perineal electrophysiologic testing in multiple sclerosis patients.
Multiple Sclerosis: Current Knowledge and Future Outlook.
In vivo Positron Emission Tomography Imaging Demonstrates Diminished Microglial Activation after Fingolimod Treatment in an Animal Model of Multiple Sclerosis.
Current status of chemokines in the adult CNS.
Mimics and rare presentations of pediatric demyelination.
Accelerated Axonal Loss Following Acute CNS Demyelination in Mice Lacking Protein Tyrosine Phosphatase Receptor Type Z.
[Multiple sclerosis and peripheral neuropathy].
A Novel Bmal1 Mutant Mouse Reveals Essential Roles of the C-Terminal Domain on Circadian Rhythms.
[Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].
PKA Reduces the Rat and Human KCa3.1 Current, CaM Binding, and Ca2+ Signaling, Which Requires Ser332/334 in the CaM-Binding C Terminus.
Expression, purification, crystallization and preliminary X-ray crystallographic analysis of the extracellular olfactomedin domain of gliomedin.
CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation.
KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis.
Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.

Pages